MET Inhibitors in Small Cell Lung Cancer: From the Bench to the Bedside

by Max Hardy-Werbin, Raúl del Rey-Vergara, Miguel Alejandro Galindo-Campos, Laura Moliner, Edurne Arriola
Published 2019-09-01

Serum cytokine levels as predictive biomarkers of benefit from ipilimumab in small cell lung cancer

by Max Hardy-Werbin, Pedro Rocha, Oriol Arpi, Álvaro Taus, Lara Nonell, Xavier Durán, Xavier Villanueva, Deborah Joseph-Pietras, Luke Nolan, Sarah Danson, Richard Griffiths, Miguel Lopez-Botet, Ana Rovira, Joan Albanell, Christian Ottensmeier, Edurne Arriola
Published 2019-06-01

Comparison of Different Methods for Defining Hyperprogressive Disease in NSCLC

by Pedro Rocha, MD, Didac Ramal, MD, Enric Ripoll, MD, Laura Moliner, MD, Alex Corbera, MD, Max Hardy-Werbin, MD, PhD, Mayra Orrillo, MD, Álvaro Taus, MD, Flavio Zuccarino, MD, Joan Gibert, Júlia Perera-Bel, David Casadevall, MD, PhD, Edurne Arriola, MD, PhD
Published 2021-01-01